Brief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
28/05/2026 15:44
BRIEF-Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY May 28 (Reuters) - Lavipharm SA LPHr.AT:
Q1 EBITDA FROM CONTINUING OPERATIONS €3.13 MILLION UP 11.0% YOY
Q1 SALES BEFORE REBATE CLAWBACK €16.59 MILLION UP 12.8% YOY
Q1 EARNINGS BEFORE TAX FROM CONTINUING OPERATIONS €1.41 MILLION UP 28.6% YOY
Q1 DOMESTIC RX PHARMACEUTICAL SALES UP 32.2% YOY
SEES GROUP’S EXPORT ACTIVITY FOR FY 2026 TO SHOW GROWTH COMPARED TO 2025
Further company coverage: [LPHr.AT]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY